Upload Avatar (500 x 500)
Benhong Zhou
benhongzh@163.com
Chinese, English
Hubei
Wuhan University
Medical School
  • 1984-1988 Bachelor of Pharmacy, Hubei University of Chinese Medicine
  • 1996-1999 Master of Medical Science in Pharmacology, Wuhan University Medical School (formerly Hubei Medical University)
  • 2003-2007 Doctor of Science in Organic Chemistry, Wuhan University
  • Short-term training at Johns Hopkins University School of Medicine, USA, December 2016
  • Over 10 national and provincial level projects undertaken
  • 6 National Natural Science Funds approved
  • 3 invention patents granted
  • 1988-1994 Pharmacist, First Affiliated Hospital of Hubei Medical University
  • 1994-1999 Chief Pharmacist, First Affiliated Hospital of Hubei Medical University
  • 1999-2001 Deputy Director and Associate Professor, Department of Pharmacy, Renmin Hospital of Wuhan University
  • 2001-2015 Deputy Director of Clinical Pharmacy Research Lab, Renmin Hospital of Wuhan University (Promoted to Chief Pharmacist in 2004 and Professor in 2008)
  • 2015-2020 Deputy Director of Pharmacy Department and Clinical Pharmacy Research Lab, Renmin Hospital of Wuhan University (Promoted to First-Level Chief Pharmacist in 2020)
  • 2021-present Director of Pharmacy Department, Chief of Pharmacy, Director of Pharmacy at Shouyi Campus, Deputy Director of Clinical Pharmacy Research Lab, Renmin Hospital of Wuhan University
  • 2010 National Level Planning Textbook 'Natural Medicine Chemistry' by Higher Education Press, Beijing, Editorial Board Member
  • 2021 National Level Planning Textbook 'Pharmaceutical Care Practice' by China Medical Science and Technology Press, Beijing, Editorial Board Member
  • 2021 'Hubei Authentic and Characteristic Medicinal Materials' by Hubei Science and Technology Press, Hubei, Editorial Board Member
  • 2009 Higher Education Planning Textbook 'Chinese Medicine Pharmaceutical Technology and Design' by Chemical Industry Press, Beijing, Deputy Editor
  • 2019 'Transdermal Administration of Chinese Medicine and Functional Cosmetics' by China Medical Publishing House, Beijing
  • 2003 Synthesis of Lotusine Derivatives and Their Anti-Arrhythmic Effects Study, Hubei Provincial Science and Technology Department, Reached Domestic Leading Level
  • 2010 Development and Clinical Application of Sugar-Free Shenning Granules, Hubei Provincial Science and Technology Department, Reached Domestic Leading Level
  • 2015 HPLC Quantitative Detection and Stability in Pain Pumps of Butorphanol Postoperative Multimodal Analgesia Solution, Hubei Provincial Science and Technology Department, Reached Domestic Leading Level
  • 1997 Chinese Medicine Freckle-Removing Beauty Cream for Pigmentary Skin Diseases Study and Clinical Research, Hubei Provincial Medical Science and Technology Progress Third Prize
  • 2017 Construction and Clinical Application of a Safe and Rational Drug Use System for Postoperative Multimodal Analgesia, Hubei Provincial Science and Technology Progress Third Prize
Active ingredients of Traditional Chinese Medicine and natural medicine
Clinical metabolism pharmacology
Pharmacoeconomics
  • Recent Advances and Perspectives on the Health Benefits of Urolithin B, A Bioactive Natural Product Derived From Ellagitannins, Zhou, B.H*., Chen, P., Guo, Z.I., Chen, F.C., Wu, Y., 2022
  • Serum Metabolomics Analysis of the Anti-Inflammatory Effects of Gallic Acid on Rats With Acute Inflammation, Zhou, B.H*., Wu, Y., Li, K.Y., Zeng, M.L., Qiao, B.Y., 2022
  • Urolithin A alleviates acute kidney injury induced by renal ischemia reperfusion through the p62-Keap1-Nrf2 signaling pathway, Zhou, B.H*., Zhang, Y., Liu, M.M., Zhang, Y.Y., Tian, M., Chen, P., Lan, Y., 2022
  • The Gut Microbiota Metabolite Urolithin B Improves Cognitive Deficits by Inhibiting Cyt C-Mediated Apoptosis and Promoting the Survival of Neurons Through the PI3K Pathway in Aging Mice, Zhou, B.H*., Chen, P., Chen, F.C., Lei, J.X., Wang, G.H., 2021
  • Gut microbial metabolite urolithin b attenuates intestinal immunity function in vivo in aging mice and in vitro in ht29 cells by regulating oxidative stress and inflammatory signalling, Zhou, B.H*., Chen, P., Chen, F., Lei, J.X., 2021
  • Oral absorption mechanism of the polysaccharides from Gastrodia elata Blume base on fluorescence labeling, Zhou, B.H*., Zhang, B.Y., Liu, M.M., Liu, G., Li, D., 2021
  • Urolithin A attenuates renal fibrosis by inhibiting TGF-beta 1/Smad and MAPK signaling pathways, Zhou, B.H*., Cheng, Z.Z., Tu, J.J., Zhang, H.P., Zhang, Y., 2021
  • Effect of punicalagin on multiple targets in streptozotocin / high-fat diet induced diabetic mice, Zhou, B. H*., Jin, D., Zhang, B.Y., Li, Q. L., Tu, J. J., 2020
  • Gallic acid inhibits bladder cancer T24 cell progression through mitochondrial dysfunction and pi3k/akt/nf-κb signaling suppression, Zhou, B.H*., Zeng, M.L, Su, Y., Li, K.Y, Jin, D., 2020
  • Sacubitril-Valsartan Compared With En
Traditional Chinese Medicine Natural Medicine Active Ingredients Clinical Metabolism Pharmacology Pharmacoeconomics Research Clinical Trials Natural Products Medicinal Chemistry

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.